Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Uncategorized

Uncategorized

GSK-spinoff Haleon expects top-end 2023 organic sales growth.

The company logo for Haleon and the trading info is displayed on a screen on the floor of the New Yo... The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022. REUTERS/Brendan McDermid
The company logo for Haleon and the trading info is displayed on a screen on the floor of the New Yo... The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022. REUTERS/Brendan McDermid

Listen to the article now

On Thursday, consumer healthcare business Haleon (HLN.L) said it expected 2023 organic sales,

growth near the top of its 4%-6% prediction owing to high demand and restocking of its respiratory,

health products after a terrible cold and flu season.

The world’s largest standalone consumer health business, which offers non-prescription medications, vitamins, and dental care, maintained its full-year 2023 outlook.

GSK (GSK.L) spun off Haleon in July.

 

 


Comment Template

You May Also Like

Business

In response to recent US tariffs on Canadian goods, Ontario imposed a 25% levy on electricity exports to New York, Michigan, and Minnesota. This...

Business

Major US market indices fell significantly, with the S&P 500 reaching a six-month low. This slump coincides with growing concerns about a probable US...

Business

Hims & Hers Health reported strong Q4 2024 revenue growth, surpassing expectations, but its stock fell 18% due to margin concerns and regulatory scrutiny...

Business

The Saver’s Credit helps low- and moderate-income earners reduce their tax bill while saving for retirement. Many eligible taxpayers miss out due to low...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok